Most global healthcare resources are focused on COVID19 and this is largely disrupting the continuum of care for patients with chronic diseases (Chudasama et al., 2020).

Algocyte is helping change how frequently and where people are monitored and get tested, but most people (89%) are still at high risk of infection from travelling…

IA’s CTO Dr. Jürgen Riedel and Senior AI Researcher Dr. Santiago Hernández-Orozco delivered an invited technical talk at the international conference AUTOMATA 2020, the 26th International Workshop on Cellular…

AUTOMATA 2020 will focus on the theory and applications that many of OIA’s own proprietary methods are based upon, on the deep connections of discrete dynamical systems complexity…

OIA has been nominated to the OBN awards for the Best Start-up Medtech in the UK. The awards celebrate outstanding achievement throughout the life sciences industry.

OIA has become a sponsor and will join CogX 2020 as an exhibitor with a dedicated virtual booth. CogX is the Festival of AI and Emerging Technology and will take place on the 8th-10th June 2020.

The FQXi catalyses, supports, and disseminates research on questions at the foundations of physics, particularly new frontiers and innovative ideas integral to a deep understanding of reality.

Our CEO, Dr. Hector Zenil, will be delivering the opening Keynote at the Predictive Analytics World summit on May 11, 2020 originally planned to be held in Munich, Germany but now to be held online.

According to the organisers, STHLM TECH is the largest startup event in Europe where every geek, hacker, entrepreneur, investor, and designer around Stockholm comes together under one roof.

Oxford Immune Algorithmics (OIA), like almost every other company and organisation around the world is putting in place contingency plans to downsize operations…

We have successfully closed our latest funding round with SFC and KIN Capital leading it, award winning investors, both joining last week our multinational shareholder’s board supporting OIA.

Oxford Immune Algorithmics (OIA) has been chosen one of 50 game-changers in the Thames Valley (UK’s Silicon Valley) for the creation of Algocyte and our responsible AI approaches…

Oxford Immune Algorithmics (OIA) is very proud to have partnered with the University of Reading and welcomes two of their students in Computer Science hired with the partial support of the University of Reading…

We are very excited to share the announcement that we have accomplished a major milestone getting Algocyte® certified under the European Commission medical device directive.

OIA will be exhibiting at one of the world’s leading summits on AI in medicine, Intelligent Health 2020 on 5 February 2020 at a prime venue, the ExCel, London, U.K. where we will be promoting Algocyte, our flagship product for end-to-end remote blood testing…

Promoted and streamed online worldwide and to the Austin Vita offices in Germany and the U.S., as advertised locally in Reading’s giant screen at the train station, six speakers welcomed 80 attendants

Oxford Immune Algorithmics & Austin Vita Invite You To ‘AI In Healthcare’

Organised in partnership with the NHSx, Intelligent Health UK is the World’s Leading AI in Medicine Summit, 5 February 2020 | London | UK

OIA’s first anniversary was this past September 25th and the University of Oxford planted a 4-year old beech tree in honour of Oxford Immune Algorithmics (OIA) at the Oxford University premises in Wytham…

OIA will be at the the early stage life sciences investment event to be held at Level39 in Canary Wharf, London, January 20, 2020.